The predictive value of the preoperative systemic immune‐inflammation index in the occurrence of postoperative pneumonia in non‐small cell lung cancer: A retrospective study based on 1486 cases

To investigate the correlation between the preoperative systemic immune‐inflammation index (pSII) and postoperative pneumonia (POP) in surgical non‐small cell lung cancer patients.

[1]  Ran Xu,et al.  The MLR, NLR, PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgery , 2022, BMC Pulmonary Medicine.

[2]  N. Rezaei,et al.  Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis , 2021, Frontiers in Immunology.

[3]  Haiquan Chen,et al.  Systemic immune-inflammation index is a stage-dependent prognostic factor in patients with operable non-small cell lung cancer , 2021, Translational lung cancer research.

[4]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[5]  D. Cai,et al.  Preoperative peripheral blood neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms predict the survival of patients with limited-stage small-cell lung cancer , 2021, Translational lung cancer research.

[6]  F. Tan,et al.  Preoperative systemic immune-inflammation index and prognostic nutritional index predict prognosis of patients with pulmonary neuroendocrine tumors after surgical resection , 2020, Annals of translational medicine.

[7]  He Xiao,et al.  Utilization of combined PD-L1 expression and neutrophil-to-lymphocyte ratio prior to surgery as a prognostic factor in non-small cell lung cancer with brain metastasis , 2019, Translational cancer research.

[8]  David R. Jones,et al.  Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). , 2018, The Lancet. Respiratory medicine.

[9]  Michel Wolff,et al.  Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. , 2017, The Cochrane database of systematic reviews.

[10]  S. Cai,et al.  Prognostic value of systemic immune-inflammation index in patients with gastric cancer , 2017, Chinese journal of cancer.

[11]  R. Kradin,et al.  The pathology of pulmonary bacterial infection. , 2017, Seminars in diagnostic pathology.

[12]  J. Mizgerd.  Pathogenesis of severe pneumonia: advances and knowledge gaps , 2017, Current opinion in pulmonary medicine.

[13]  D. Thickett,et al.  Long-term impact of developing a postoperative pulmonary complication after lung surgery , 2016, Thorax.

[14]  P. Mazzone,et al.  Association of impaired heart rate recovery with cardiopulmonary complications after lung cancer resection surgery. , 2015, The Journal of thoracic and cardiovascular surgery.

[15]  Q. Jia,et al.  Tumor-infiltrating memory T-lymphocytes for prognostic prediction in cancer patients: a meta-analysis. , 2015, International journal of clinical and experimental medicine.

[16]  D. McMillan,et al.  Routine clinical markers of the magnitude of the systemic inflammatory response after elective operation: a systematic review. , 2015, Surgery.

[17]  W. Guo,et al.  Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma , 2014, Clinical Cancer Research.

[18]  B. Stanger,et al.  Platelets and tumor cells: a new form of border control. , 2013, Cancer cell.

[19]  G. D. de Bock,et al.  The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis , 2011, British Journal of Cancer.

[20]  L. Klassen,et al.  Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. , 1985, Journal of immunology.